Irwin Melinda L, McTiernan Anne, Bernstein Leslie, Gilliland Frank D, Baumgartner Richard, Baumgartner Kathy, Ballard-Barbash Rachel
Department of Epidemiology and Public Health, Yale School of Medicine, P.O. Box 208034, New Haven, CT 06520-8034, USA.
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2881-8. doi: 10.1158/1055-9965.EPI-05-0185.
Obese and physically inactive breast cancer patients may have poorer survival compared with lighter weight and more active women. Several obesity-related and physical activity-related hormones and peptides may explain this association, including insulin, leptin, insulin-like growth factor-I (IGF-I), and IGF-binding protein-3. Few studies have examined the associations between obesity, physical activity, and these hormones/peptides among breast cancer survivors.
To determine whether obesity and physical activity are associated with insulin, IGFs, and leptin levels in a population-based sample of 710 women diagnosed with in situ to stage IIIA breast cancer and enrolled in the Health, Eating, Activity, and Lifestyle Study.
We collected a blood sample and information on physical activity among women diagnosed 2 to 3 years earlier using an interview-administered questionnaire. Trained staff measured weight. C-peptide, leptin, and IGFs were assayed by RIA. Mean hormone levels within body mass index and physical activity categories were adjusted for confounders using analysis of covariance methods.
We observed higher C-peptide (P for trend = 0.0001) and leptin (P for trend = 0.0001) levels and lower IGF-I levels (P for trend = 0.0001) with higher levels of body mass index. We observed lower C-peptide (P for trend = 0.001) and leptin (P for trend = 0.001) levels and higher IGF-I (P for trend = 0.0037) and IGF-binding protein-3 (P for trend = 0.055) levels with higher levels of physical activity.
Increasing physical activity and decreasing body fat may be a reasonable intervention approach toward changing insulin and leptin, thereby potentially influencing breast cancer prognosis.
与体重较轻且活动较多的女性相比,肥胖且缺乏身体活动的乳腺癌患者可能生存率更低。几种与肥胖和身体活动相关的激素及肽类可能解释这种关联,包括胰岛素、瘦素、胰岛素样生长因子-I(IGF-I)和IGF结合蛋白-3。很少有研究探讨乳腺癌幸存者中肥胖、身体活动与这些激素/肽类之间的关联。
在一项基于人群的样本中,确定肥胖和身体活动是否与710名诊断为原位癌至IIIA期乳腺癌且参与健康、饮食、活动及生活方式研究的女性的胰岛素、IGF和瘦素水平相关。
我们通过访谈问卷收集了2至3年前被诊断的女性的血样及身体活动信息。训练有素的工作人员测量体重。采用放射免疫分析法测定C肽、瘦素和IGF。使用协方差分析方法对体重指数和身体活动类别内的平均激素水平进行混杂因素校正。
我们观察到,随着体重指数升高,C肽水平(趋势P = 0.0001)和瘦素水平(趋势P = 0.0001)升高,而IGF-I水平降低(趋势P = 0.0001)。我们还观察到,随着身体活动水平升高,C肽水平(趋势P = 0.001)和瘦素水平(趋势P = 0.001)降低,而IGF-I水平(趋势P = 0.0037)和IGF结合蛋白-3水平(趋势P = 0.055)升高。
增加身体活动和减少体脂可能是改变胰岛素和瘦素水平的合理干预方法,从而可能影响乳腺癌预后。